CATX position history
The shares of Perspective Therapeutics (CATX) that Avidity Partners Management LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2024 Q2: 3,037,668 shares, $30M, 1.3% of portfolio, New
- 2024 Q3: 3,444,002 shares, $46M, 2.3% of portfolio, Add +13.4%
- 2024 Q4: 2,694,600 shares, $8.6M, 0.84% of portfolio, Reduce −21.8%
- 2025 Q1: 2,197,270 shares, $4.7M, 0.89% of portfolio, Reduce −18.5%
- 2025 Q2: 1,858,596 shares, $6.4M, 1.3% of portfolio, Reduce −15.4%
- 2025 Q3: 2,994,033 shares, $10M, 2.3% of portfolio, Add +61.1%
- 2025 Q4: 3,210,733 shares, $8.8M, 2.5% of portfolio, Add +7.2%
- 2026 Q1: 12,099,998 shares, $49M, 5.3% of portfolio, Add +276.9%
- 2026 Q2: 6,299,999 shares, $21M, 3.4% of portfolio, Reduce −47.9%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|